스피로놀락톤 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "스피로놀락톤" in Korean language version.

Last modified: 04:53:03, 14 April 2025 (UTC)

Ref.Un. Ref.Website

Global rank Korean rank

125nih.gov

5^th place

4^th place

104doi.org

2^nd place

3^rd place

93worldcat.org

4^th place

6^th place

44books.google.com

3^rd place

7^th place

11aspetjournals.org

8,671^st place

3,902^nd place

11web.archive.org

1^st place

11drugs.com

529^th place

121^st place

aspetjournals.org (Global: 8,671^st place; Korean: 3,902^nd place)

dmd.aspetjournals.org

Los LE, Pitzenberger SM, Ramjit HG, Coddington AB, Colby HD (1994). “Hepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites”. 《Drug Metab. Dispos.》 22 (6): 903–8. PMID 7895608.

books.google.com (Global: 3^rd place; Korean: 7^th place)

Andrew Parkinson (2001). 《Biotransformation of Xenobiotics》. McGraw-Hill. 137–138,169,171,180,195,208쪽.
Curtis D. Klaassen (2007년 12월 11일). 《Casarett & Doull's Toxicology: The Basic Science of Poisons, Seventh Edition》. McGraw Hill Professional. 173쪽. ISBN 978-0-07-159351-9. Some P450 enzymes (such as the rate enzyme CYP2A1) preferentially catalyze the 6α-hydroxylation reaction, whereas other P450 enzymes (such as the CYP3A enzymes in all mammalian species) preferentially catalyze the 6β-hydroxylation reaction (which is a major route of hepatic steroid biotransformation).
Henry R. Black; William Elliott (2006년 12월 28일). 《Hypertension: A Companion to Braunwald's Heart Disease》. Elsevier Health Sciences. 295–쪽. ISBN 978-1-4377-1078-6.
NADIR R. FARID; Evanthia Diamanti-Kandarakis (2009년 2월 27일). 《Diagnosis and Management of Polycystic Ovary Syndrome》. Springer Science & Business Media. 235–쪽. ISBN 978-0-387-09718-3.

doi.org (Global: 2^nd place; Korean: 3^rd place)

dx.doi.org

Sica, Domenic A. (2005). “Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium Homeostasis”. 《Heart Failure Reviews》 10 (1): 23–29. doi:10.1007/s10741-005-2345-1. ISSN 1382-4147. PMID 15947888.
Carone, Laura; Oxberry, Stephen G.; Twycross, Robert; Charlesworth, Sarah; Mihalyo, Mary; Wilcock, Andrew (2017). “Spironolactone”. 《Journal of Pain and Symptom Management》 53 (2): 288–292. doi:10.1016/j.jpainsymman.2016.12.320. ISSN 0885-3924. PMID 28024992.
Takamura, Norito; Maruyama, Toru; Ahmed, Shamim; Suenaga, Ayaka; Otagiri, Masaki (1997). “Interactions of Aldosterone Antagonist Diuretics with Human Serum Proteins”. 《Pharmaceutical Research》 14 (4): 522–526. doi:10.1023/A:1012168020545. ISSN 0724-8741.
Draganov DI, La Du BN (January 2004). “Pharmacogenetics of paraoxonases: a brief review”. 《Naunyn Schmiedebergs Arch. Pharmacol.》 369 (1): 78–88. doi:10.1007/s00210-003-0833-1. PMID 14579013.

drugs.com (Global: 529^th place; Korean: 121^st place)

“Spironolactone”. The American Society of Health-System Pharmacists. 2015년 11월 16일에 원본 문서에서 보존된 문서. Oct 24, 2015에 확인함.

nih.gov (Global: 5^th place; Korean: 4^th place)

ncbi.nlm.nih.gov

Sica, Domenic A. (2005). “Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium Homeostasis”. 《Heart Failure Reviews》 10 (1): 23–29. doi:10.1007/s10741-005-2345-1. ISSN 1382-4147. PMID 15947888.
Maron BA, Leopold JA (2008). “Mineralocorticoid receptor antagonists and endothelial function”. 《Curr Opin Investig Drugs》 9 (9): 963–9. PMC 2967484. PMID 18729003.
Carone, Laura; Oxberry, Stephen G.; Twycross, Robert; Charlesworth, Sarah; Mihalyo, Mary; Wilcock, Andrew (2017). “Spironolactone”. 《Journal of Pain and Symptom Management》 53 (2): 288–292. doi:10.1016/j.jpainsymman.2016.12.320. ISSN 0885-3924. PMID 28024992.
Los LE, Pitzenberger SM, Ramjit HG, Coddington AB, Colby HD (1994). “Hepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites”. 《Drug Metab. Dispos.》 22 (6): 903–8. PMID 7895608.
Draganov DI, La Du BN (January 2004). “Pharmacogenetics of paraoxonases: a brief review”. 《Naunyn Schmiedebergs Arch. Pharmacol.》 369 (1): 78–88. doi:10.1007/s00210-003-0833-1. PMID 14579013.

web.archive.org (Global: 1^st place; Korean: 1^st place)

“Spironolactone”. The American Society of Health-System Pharmacists. 2015년 11월 16일에 원본 문서에서 보존된 문서. Oct 24, 2015에 확인함.

worldcat.org (Global: 4^th place; Korean: 6^th place)

Sica, Domenic A. (2005). “Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium Homeostasis”. 《Heart Failure Reviews》 10 (1): 23–29. doi:10.1007/s10741-005-2345-1. ISSN 1382-4147. PMID 15947888.
Carone, Laura; Oxberry, Stephen G.; Twycross, Robert; Charlesworth, Sarah; Mihalyo, Mary; Wilcock, Andrew (2017). “Spironolactone”. 《Journal of Pain and Symptom Management》 53 (2): 288–292. doi:10.1016/j.jpainsymman.2016.12.320. ISSN 0885-3924. PMID 28024992.
Takamura, Norito; Maruyama, Toru; Ahmed, Shamim; Suenaga, Ayaka; Otagiri, Masaki (1997). “Interactions of Aldosterone Antagonist Diuretics with Human Serum Proteins”. 《Pharmaceutical Research》 14 (4): 522–526. doi:10.1023/A:1012168020545. ISSN 0724-8741.

스피로놀락톤 (Korean Wikipedia)

aspetjournals.org (Global: 8,671st place; Korean: 3,902nd place)

dmd.aspetjournals.org

books.google.com (Global: 3rd place; Korean: 7th place)

doi.org (Global: 2nd place; Korean: 3rd place)

dx.doi.org

drugs.com (Global: 529th place; Korean: 121st place)

nih.gov (Global: 5th place; Korean: 4th place)